Medicare AdvantageCoverageMedium impact
Penile Prosthesis Implant for Erectile Dysfunction - Medicare Advantage (Revised)
Humana·Urology·Medicare Advantage
Effective date
Aug 3, 2026
We identified it
Aug 4, 2026
Summary
This is a revised Medicare Advantage policy (effective 08/03/2026) clarifying coverage criteria for penile prosthesis implants for erectile dysfunction. The policy establishes specific medical necessity requirements including comprehensive history/exam, documented failure of conservative management, and 6-month persistence of ED. Additionally, the policy explicitly excludes coverage for vacuum erection devices, stem cell therapy, and shockwave therapy (LI-ESWT) due to insufficient evidence.
Action Required
By August 3, 2026: Billing and prior authorization teams must update policies and workflows for Medicare Advantage plans. (1) For penile prosthesis implants (CPT 54400, 54401, 54405, 54406, 54410, 54411, 54416): Require documentation of comprehensive medical/sexual/psychosocial history, physical exam, documented failure/contraindication/intolerance to conservative management (e.g., intracavernosal injection, medications), and ED persisting ≥6 months before approving or processing claims. Update prior authorization templates and denial protocols to enforce these criteria. (2) For vacuum erection devices (HCPCS L7900, L7902): These are NOT covered under Medicare Advantage; update billing system to automatically deny claims and notify providers. (3) For stem cell therapy (CPT 38240, 38241) and shockwave therapy/LI-ESWT (CPT 0864T): These are NOT medically reasonable and necessary; update system to deny all claims for these codes. Add decision logic to EMR/billing software to flag and reject requests. Communicate non-coverage to urology providers and update encounter forms. Failure to comply will result in claim denials and potential overpayments.